FIELD: chemistry.
SUBSTANCE: synthesis method by 13C-linoleic, 13C-linolenic, 14C-linoleic and 14C-linolenic acids includes the carbon dioxide condensation, marked by 14C or 13C, with the Grignard reagent, produced from 1-bromo-8.11-heptadecandiene (in case of linoleic acid) or from 1-bromo-8.11.14-heptadecanthriene (in the case of linolenic acid), carried out in the following sequence of steps: a - production of the Grignard reagent by the reaction of metallic magnesium with 1-bromo-8.11-heptadecandiene (in case of linoleic acid) or with 1-bromo-8.11.14-heptadecantriene (in case of linolenic acid) in the presence of metallic iodine; b - carboxylation of the Grignard reagent, produced at point a, for 5-15 min at temperature -20°C at constant stirring, carbon dioxide, marked by 14C or 13C, produced by the sulfuric acid of barium carbonate decomposition, marked by 14C and 13C, at the CO2 pressure of not more than 500 mm Hg. (maintaining by the drop metering of sulfuric acid); after stopping the pressure change in the system, the reaction flask is cooled with the liquid nitrogen in order to provide the quantitative transfer of the remaining in the system 14CO2 or 13CO2 in it, close the tap connecting the device to the CO2 source, and the reaction mixture is stirred for 15 minutes at the temperature -20°C with the purpose to fully incorporate the isotopically marked carbon dioxide into the product of the synthesis: linoleic or linolenic acid.
EFFECT: target products manufacture process acceleration, reduction of carbon dioxide losses, increase of its total chemical and radiation yield in comparison with the prototype, and elimination of the isotope-marked atoms distribution along the entire length of the acyl chain, the simplification and cheapening of the target products the linoleic and linolenic acids manufacture process, is ensured by the decrease in the duration, the increase of the radiation and chemical yield of the product along the source of the isotope in comparison with the prototype, the radioactive wastes release into the external environment is almost completely excluded, as its inclusion into the target product is approaching to the quantitative.
10 tbl, 2 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
WAY OF RECEPTION OF ISOTOPE-MARKED C POLYNONSATURATED FAT ACIDS | 2007 |
|
RU2361922C1 |
EFFICACY OF FOOD DHA-PHOSPHOLIPID FOR BRAIN DHA AND DPA ACCRETION IN NEONATES | 2014 |
|
RU2662777C2 |
METHOD FOR PREPARING ALKANESULFONYLPYRIDINES | 2002 |
|
RU2224747C1 |
METHOD FOR NONINVASIVE DIAGNOSTICS OF HELICOBACTER INFECTION | 2001 |
|
RU2229714C2 |
METHOD OF PRODUCING D-GLUCOSE LABELLED WITH CARBON ISOTOPE IN POSITION 1 | 2010 |
|
RU2425051C1 |
METHOD FOR PREPARING SATURATED ALIPHATIC CARBOXYLIC ACIDS AND METHODS FOR PREPARING THEIR DERIVATIVES (VARIANTS) | 2006 |
|
RU2311402C1 |
METHOD OF PRODUCING METHYL FORMATE, TRACED WITH STABLE CARBON ISOTOPE C | 2015 |
|
RU2602081C1 |
METHOD FOR NON-INVASIVE DIAGNOSIS OF HELICOBACTER PYLORI INFECTION USING 13C-UREASE BREATH TEST | 2022 |
|
RU2790397C1 |
METHOD FOR PREVENTION OF ADVERSE EFFECT OF GENERAL TOXIC AND GENOTOXIC ACTION OF NANOSILVER ON HUMAN BODY | 2013 |
|
RU2530639C1 |
METHOD OF OBTAINING SODIUM HYDROCARBONATE, CONTAINING STABLE ISOTOPE C | 2012 |
|
RU2511388C1 |
Authors
Dates
2017-09-12—Published
2016-08-12—Filed